News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Glycology, Inc. Releases New And Improved Celsync (TM)

7/31/2006 10:39:58 AM

PHILADELPHIA, July 31 /PRNewswire-FirstCall/ -- Glycology, Inc. announced that, effective today, a new and improved anti aging food supplement Celsync(TM), is available at at an introductory offer of two bottles for the price of one.

It has been scientifically proven that there are specific all-natural nutrients (supercarbs) that have special importance in maintaining good health. These nutrients combine with proteins to form glycoproteins on the surface of all of our cells. What does this mean? As Nobel Laureates have pointed out, cells are empowered to communicate with each other chemically. Without the proper chemical coating of the cells, the cells may communicate improperly. What do the cells communicate? They communicate cell needs, such as cell repair, defense, nutrition, and immune regulation.

Do we receive these important supercarbs in our normal diet? Actually, because of changes in our diets and the packaging of foods over the last two decades, we probably only receive a few! Even though our bodies can manufacture some, this adds a needless step towards maintaining our good health. We now have a much simpler way of making certain that we receive these important and special supernutrients, Celsync(TM).

Celsync(TM) contains these critical super nutrients that are essential to the proper functioning of our cells, especially in the area of our immune system. Not only does this allow the proper functioning of our immune system to fend off infections, but it also may help slow down the aging process and prevent or retard such things as the development of cancer, diabetes, rheumatoid arthritis, osteoarthritis, lupus, chronic fatigue syndrome, multiple sclerosis, and other diseases. Celsync(TM) is safe, a proprietary blend of all-natural, unaltered food elements, and is nontoxic. By simply taking Celsync(TM) capsules, we can ensure that we are helping to maintain the health of our cells, and thereby retard the aging process and enhance the health of our bodies.

One of many testimonials:

Hi, I have been on Celsync going into my second week and I am truly amazed! I purchased a years supply but as I tell others about it, I have had to give away some of mine.

I have a ministry that is a 501 c 3 tax-exempt ministry and my goal is to bring health and healing to the people of God!

Also I am very impressed with the price of your product. Keep up the good work! Be Blessed! Evangelist Linda Brookins Allen Women IN God's Service International Ministries, Inc. About Glycology, Inc.

Glycology, Inc. is an innovative life sciences company committed to developing and commercializing new technology. The company's flagship product is Celsync(TM); a breakthrough dietary supplement based Nobel Prize winning molecular science as well as new cutting edge molecular Glycobiology technology which is just beginning to revolutionize the world of natural medicine as we know it.

Glycology is also developing a product line of advanced beauty and health products containing supercarbs and botanicals. These include Bionutrient Hair Cleansers with Celsync(TM) added, a Nutritional Scalp Therapy product with Celsync(TM) added, and a super nutrient Scalp Treatment system with a Celsync(TM) formulation.

Corporately, Glycology, Inc. currently has 10,853,000 shares outstanding and is traded OTC (GYLG)

For more information about Glycology, Inc go to or Celsync(TM), go to

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, technical development risks, seasonality and other risk factors.

CONTACT: Mark Taggatz Investor Relations 1-800-609-6517 ext 701

Glycology, Inc.

CONTACT: Mark Taggatz, Investor Relations for Glycology, Inc.,1-800-609-6517 ext 701

Read at

comments powered by Disqus